Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647644 · ClinicalTrials.gov registry record
Coagulation Test Changes Associated With Acute Normovolemic Hemodilution in Cardiac Surgery
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 80
- Enrollment target
NCT03647644: Completed study, sponsored by Mayo Clinic.
NCT03647644 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03647644 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The researchers are trying to reduce the need for blood transfusions in subjects having surgery that will involve the use of cardiopulmonary bypass. A unit of whole blood will be removed as part of their standard of care prior to going on cardiopulmonary bypass (CPB). This unit is given back to the subject post CPB. This has been shown to reduce the need for blood transfusion in patients.
Primary Outcome
A platelet is a tiny piece of cell that is made by breaking off of a large cell in the bone marrow. Platelets are found in the blood and spleen. They help form blood clots to slow or stop bleeding, and to help wounds heal. Also called thrombocyte. Normal platelet count ranges from 150,000 to 450,000 platelets per microliter of blood. Units: 10(9)/L
Interventions
- DIAGNOSTIC_TEST Coagulation Laboratory Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-01-31 |
| Est. Completion | 2018-10-11 |
What the finished NCT03647644 record still lists
NCT03647644 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Coagulation Laboratory Testing is the first listed.
NCT03647644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03647644 about?
NCT03647644 is a clinical study titled "Coagulation Test Changes Associated With Acute Normovolemic Hemodilution in Cardiac Surgery". The researchers are trying to reduce the need for blood transfusions in subjects having surgery that will involve the use of cardiopulmonary bypass. A unit of whole blood will be removed as part of their standard of care prior to going on cardiopulmonary bypass (CPB). This unit is given back to the ...
What is the current status of trial NCT03647644?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2018-01-31. Estimated completion is 2018-10-11.
What interventions are being tested in trial NCT03647644?
The interventions under investigation include: Coagulation Laboratory Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03647644?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI